Please assess the completion status of the following clinical trial:

Trial Title: Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~- Healthy male and female subjects~Exclusion criteria:~- Any relevant deviation from healthy condition.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Fixed dose combination (Type: EXPERIMENTAL): Single dose empagliflozin/metformin
- Single tablets combination (Type: ACTIVE_COMPARATOR): single doses empagliflozin and metformin

Based on this trial design, predict the completion outcome and termination type (if applicable).